Literature DB >> 11399449

HIV Seroprevalence among newly incarcerated inmates in the Texas correctional system.

Z H Wu1, J Baillargeon, J J Grady, S A Black, K Dunn.   

Abstract

PURPOSE: The seroprevalence of HIV infection was examined among a sample of incoming inmates in the Texas Department of Criminal Justice prison system. Rates were compared across sociodemographic factors and three types of prison facilities: substance abuse felony punishment units (SAFPs), state jails, and prisons.
METHODS: The study sample consisted of 4386 incoming inmates incarcerated for any duration, dating from November 1, 1998, to May 31, 1999.
RESULTS: Among males, inmates entering state jails had a higher HIV infection rate (3.7%) than either inmates entering prisons (1.9%) or those entering SAFPs (0.5%). Among females, inmates entering prisons had a higher rate of infection (9.3%) than those entering state jails (2.5%) or SAFPs (4.5%).
CONCLUSIONS: Although a number of blinded HIV seroprevalence studies have been conducted in U.S. prison systems, scarce information is currently available on HIV infection rates in alternative correctional facilities. The present study shows that HIV seropositivity varied substantially according to race, gender, and prison facility type. Given the shorter incarceration periods for inmates held in alternative facilities, understanding how infection rates vary according to type of incarceration facility holds particular public health relevance.

Entities:  

Mesh:

Year:  2001        PMID: 11399449     DOI: 10.1016/s1047-2797(01)00210-1

Source DB:  PubMed          Journal:  Ann Epidemiol        ISSN: 1047-2797            Impact factor:   3.797


  11 in total

1.  Predictors of reincarceration and disease progression among released HIV-infected inmates.

Authors:  Jacques Baillargeon; Thomas P Giordano; Amy Jo Harzke; Anne C Spaulding; Z Helen Wu; James J Grady; Gwen Baillargeon; David P Paar
Journal:  AIDS Patient Care STDS       Date:  2010-06       Impact factor: 5.078

2.  Drug use, hepatitis C, and service availability: perspectives of incarcerated rural women.

Authors:  Michele Staton-Tindall; J Matthew Webster; Carrie B Oser; Jennifer R Havens; Carl G Leukefeld
Journal:  Soc Work Public Health       Date:  2015

3.  From corrections to communities as an HIV priority.

Authors:  David Vlahov; Sara Putnam
Journal:  J Urban Health       Date:  2006-05       Impact factor: 3.671

Review 4.  The HIV Care Cascade Before, During, and After Incarceration: A Systematic Review and Data Synthesis.

Authors:  Princess A Iroh; Helen Mayo; Ank E Nijhawan
Journal:  Am J Public Health       Date:  2015-05-14       Impact factor: 9.308

5.  Cancer screening among jail inmates: frequency, knowledge, and willingness.

Authors:  Ingrid A Binswanger; Mary C White; Eliseo J Pérez-Stable; Joe Goldenson; Jacqueline Peterson Tulsky
Journal:  Am J Public Health       Date:  2005-10       Impact factor: 9.308

6.  Evaluation of WaySafe: A Disease-Risk Reduction Curriculum for Substance-Abusing Offenders.

Authors:  Wayne E K Lehman; Grace A Rowan; Jack M Greener; George W Joe; Yang Yang; Kevin Knight
Journal:  J Subst Abuse Treat       Date:  2015-05-16

7.  Deaths in the Cook County jail: 10-year report, 1995-2004.

Authors:  Seijeoung Kim; Andrew Ting; Michael Puisis; Sergio Rodriguez; Roger Benson; Connie Mennella; Faith Davis
Journal:  J Urban Health       Date:  2007-01       Impact factor: 3.671

8.  The association of neoplasms and HIV infection in the correctional setting.

Authors:  Jacques Baillargeon; Brad H Pollock; Charles T Leach; Shou-Jiang Gao
Journal:  Int J STD AIDS       Date:  2004-05       Impact factor: 1.359

9.  Incarceration, African Americans and HIV: advancing a research agenda.

Authors:  Nina Harawa; Adaora Adimora
Journal:  J Natl Med Assoc       Date:  2008-01       Impact factor: 1.798

10.  Characteristics and behaviors associated with HIV infection among inmates in the North Carolina prison system.

Authors:  David L Rosen; Victor J Schoenbach; David A Wohl; Becky L White; Paul W Stewart; Carol E Golin
Journal:  Am J Public Health       Date:  2009-04-16       Impact factor: 9.308

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.